Autoimmunity Reviews

Article	Citations
Editorial Board	236
The rationale for the use of corticosteroids in early severe Guillain-Barré syndrome	174
Editorial Board	149
“Fibromyalgia syndrome” related to Essure devices	136
Leflunomide: A safe and effective alternative in systemic lupus erythematosus	134
Proteomics and enriched biological processes in Antiphospholipid syndrome: A systematic review	98
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review	90
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective	86
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders	86
Editorial Board	85
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases	84
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis	80
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence	74
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management	69
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis	67
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch	67
Susac syndrome: A scoping review	66
Endometriosis and autoimmunity	61
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology	61
Editorial Board	61
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes	61
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction	59
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature	59
Can anticoagulation be withdrawn in APS patients after aPL negativization?	57
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.	56

Psychiatric manifestations of autoimmune encephalitis	56
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate	55
The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned	54
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy	54
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 2021	52
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases	51
Inflammatory bowel disease in primary immunodeficiency disorders is a heterogeneous clinical entity requiring an individualized treatment strategy: A systematic review	50
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination	49
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered	48
Seronegative autoimmune diseases: A challenging diagnosis	47
Autoimmunity in vitiligo: Therapeutic implications and opportunities	45
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy	44
Autoimmune pre-disease	43
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases	42
A descriptive study of IgG4-related disease in children and young adults	41
Indian Rheumatology Association guidelines for the management of ANCA associated vasculitis	41
Cardiovascular outcome in adult-onset Kawasaki disease	41
Predicting autoimmune diseases: A comprehensive review of classic biomarkers and advances in artificial intelligence	40
Editorial Board	40
Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases	40
Refining search and keyword strategies in autoimmune ear disease bibliometric studies	40
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database	40
Cerebral vasculitis as a clinical manifestation of neurosarcoidosis: A scoping review	39
Adipose failure through adipocyte overload and autoimmunity	39
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica	38
Standardised interpretation of capillaroscopy in autoimmune idiopathic inflammatory myopathies: A structured review on behalf of the EULAR study group on microcirculation in Rheumatic Diseases	36
SpA plus IBD or IBD plus SpA: Does commutative property apply?	36
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases	36
IFN-γ: An overlooked cytokine in dermatomyositis with anti-MDA5 antibodies	36
Inclusion body myositis: Correcting impaired mitochondrial and lysosomal autophagy as a potential therapeutic strategy	35
Exosomes as biomarkers and therapeutic delivery for autoimmune diseases: Opportunities and challenges	35
Histopathological features of systemic sclerosis-associated myopathy: A scoping review	35
Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium	35
Are breast cancer patients diagnosed after systemic sclerosis showing different pathological characteristics?	34
Editorial Board	34
Controversies in in rheumatology and autoimmunity: Is CORA meeting a good educational tool to increase the scientific knowledge?	33
The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases	33
Zipper method is the emerging treatment option for severe Guillain-Barre syndrome related COVID-19	33
Effects of cytotoxic T-lymphocyte-associated protein 4 compared to TNF inhibitors on lipid profile: Results from an observational multicentre rheumatoid arthritis cohort	33
Complex relationships of type 2 and type 1 symptoms across various systemic autoimmune diseases.	33
Fibromyalgia: Are we using the biopsychosocial model?	32
Antibiotic-induced gut dysbiosis and autoimmune disease: A systematic review of preclinical studies	32
Tumor necrosis factor-α inhibitor-related autoimmune disorders	31
Development of an algorithm for IgG4-related disease management	30
Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines	30
Factors associated with fertility abnormalities in women with systemic lupus erythematosus: a systematic review and meta-analysis	30
The myristoylated alanine-rich C-kinase substrates (MARCKS): A membrane-anchored mediator of the cell function	30
Factors associated with incident cardiovascular disease in patients with rheumatoid arthritis: A scoping review	28
The role of mitochondrial dysfunction in kidney injury and disease	28
Dysfunction of the glymphatic system and sleep disturbance in rheumatoid arthritis and musculoskeletal pain: A gap related to pain becoming chronic	27

Are IF-ANA the guiding light for SLE classification in the real-world setting?	27
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease	27
Reply letter to letter to the editor	27
Anti-rods/rings autoantibodies in a patient with pancreatic injury	26
Will a hyperactive classical complement pathway exacerbate autoimmune diseases?	26
Editorial Board	26
Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis	26
Twenty shades of the mosaic of autoimmunity	26
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies	25
Editorial Board	25
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechan	25
Tumors, tumor therapies, autoimmunity and the eye	24
Global burden due to modifiable risk factors for autoimmune diseases, 1990–2021: Temporal trends and socio-demographic inequalities	24
Mucous membrane pemphigoid	24
In Memoriam: Pierre Youinou	24
Differences in clinical phenotype, laboratory, and imaging manifestations between AQP4 IgG positive and AQP4 MOG IgG double negative NMOSD: How to correctly diagnose the two	24
Editorial Board	24
Alarmins in autoimmune diseases	24
Rheumatological complications of Covid 19	24
Reactive oxygen species: The Yin and Yang in (auto-)immunity	23
Editorial Board	23
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions	23
Neuroimaging in thyroid eye disease: A systematic review	23
Cutting edge confusion about cut-off settings in autoimmune diagnostics	23
From autoantibody test results to decision making: Incorporating likelihood ratios within medical practice	23
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) in 2023	22
Prevalence of immune-mediated inner ear disease in non-segmental vitiligo: A cross-sectional study	22
Mucosal immunity and rheumatoid arthritis: An update on mechanisms and therapeutic potential	22
Persistence of antiphospholipid antibodies over time and its association with recurrence of clinical manifestations: A longitudinal study from a single centre	22
Emerging role of Tissue Resident Memory T cells in vitiligo: From pathogenesis to therapeutics	22
Subcutaneous tissue involvement in idiopathic inflammatory myopathies: Systematic literature review including three new cases and hypothetical mechanisms	21
Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue	21
Editorial Board	21
Is it time for treat-to-target in antiphospholipid syndrome?	20
Diagnostic approach in giant cell arteritis	20
Persistent aortic inflammation in patients with giant cell arteritis	20
Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data	20
Epidemiology of major relapse in giant cell arteritis: A study-level meta-analysis	20
Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target	20
Risk factors associated with thrombocytopenia in systemic lupus erythematosus: A systematic review and meta-analysis	20
Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians	20
JAK inhibitors and systemic sclerosis: A systematic review of the literature	20
Ocular microvascular damage in autoimmune rheumatic diseases: The pathophysiological role of the immune system	20
Serum calprotectin is a marker of disease activity in Giant cell arteritis	20
Genetic and genomic associations in antiphospholipid syndrome: A systematic review	20
Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers	20
Inflammatory muscle involvement in systemic vasculitis: A systematic review	20
Salivary gland involvement in ANCA-associated vasculitis	20
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals	19
Editorial Board	19
From inflammation to renal fibrosis: A one-way road in autoimmunity?	19
Burden of inflammatory bowel disease among elderly, 1990–2019: A systematic analysis based on the global burden of disease study 2019	19
Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis	19
Don't mix apples and oranges. Reply to Azoulay et al.	18
Drug-induced antiphospholipid syndrome: Analysis of the WHO international database	18
Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: A systematic review and meta-analysis	18
Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care	18
COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity?	18
Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: A systematic review and met	18
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology	18
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases	17
Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent	17
Therapeutic potential of chimeric antigen receptor based therapies in autoimmune diseases	17
Structural cell heterogeneity underlies the differential contribution of IL-17A, IL-17F and IL-23 to joint versus skin chronic inflammation	17
Cerebral iron accumulation in multiple sclerosis: Pathophysiology and therapeutic implications	17
Autoimmunity and COVID-19 – The microbiotal connection	16
CCR6-CCL20 axis as a therapeutic target for autoimmune diseases	16
Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases?	16
Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis	16
Research advances on targeted-Treg therapies on immune-mediated kidney diseases	16
Intermittent fasting: A promising dietary intervention for autoimmune diseases	16
Scleroderma specific autoantibodies and MS-like manifestations: A novel association?	16
Autoantibodies against tyrosyl-tRNA synthetase (anti-Ha antibodies)	16
Glomerulonephritis and inflammatory bowel disease: A tale of gut-kidney axis dysfunction	16
The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity	16
IgG4 in the gut: Gastrointestinal IgG4-related disease or a new subtype of inflammatory bowel disease	16
The threat of triple M and autoimmune overlap syndromes with immune checkpoint inhibitors - A series of case reports	16
Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management	15
Janus kinase inhibitors for psoriatic arthritis: Evidence from a systematic review and network meta-analysis	15
Advancing understanding of autoimmune disease-related interstitial lung disease (AD-ILD): A global perspective on research focus and future directions	15

Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series	15
Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP)	15
Prevalence of anti-Ro52-kDa/SSA (TRIM21) antibodies and associated clinical phenotype in systemic sclerosis: Data from a French cohort, a systematic review and meta-analysis	15
The interferon in idiopathic inflammatory myopathies: Different signatures and new therapeutic perspectives. A literature review	15
Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus – A proposal from an expert panel	15
The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review	15
Prevention of rheumatoid arthritis using a familial predictive medicine approach	15
Insights into new-onset autoimmune diseases after COVID-19 vaccination	14
Involvement of aquaporin 5 in Sjögren’s syndrome	14
Takotsubo syndrome occurring in systemic diseases: A French multicenter retrospective case-control study and literature review	14
Early skeletal muscle manifestations in polyarteritis nodosa and ANCA-associated vasculitis	14
Prenatal and perinatal factors associated with developing multiple sclerosis later in life: A systematic review and meta-analysis	14
Covid vaccination in patients with autoimmune diseases treated with mycophenolate: Let's think back to the recommendations	14
Anti-glomerular basement membrane vasculitis	14
Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus	14
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain	14
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis	14
Editorial Board	14
Letter to the editor regarding a meta-analysis of JAK inhibitors and psoriatic arthritis	14
Editorial Board	14
Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy and COVID19 vaccination: Correspondence	14
Multiple sclerosis and pregnancy: Pathogenesis, influencing factors, and treatment options	14